COMMUNIQUÉS West-GlobeNewswire

Nokia launches portfolio of digital health products designed to inspire people to take control of their health

20/06/2017 - 09:10

Nokia expands in digital health; company announces largest line of connected consumer health products New products include Nokia Body BMI Wi-Fi connected scale, Nokia BPM+ soft-cuff blood pressure monitor, new Nokia [...]

Galapagos' R&D Update 2017: rapidly advancing our product candidates

20/06/2017 - 07:30

Filgotinib Darwin 3: improved activity, consistent safety parameters for filgotinib Ph2 studies initiated in 6 new indications Cystic fibrosis Three different triple combos in development Successful completion of Ph1 [...]

Novartis RTH258 (brolucizumab) demonstrates robust visual gains in nAMD patients with a majority on a 12-week injection interval

20/06/2017 - 07:15

RTH258 achieved the primary efficacy endpoint of non-inferiority to aflibercept in mean change in BCVA from baseline to week 48[1],[2] in two head-to-head pivotal Phase III studies[3],[4] 57% and 52% of patients [...]

Novartis real world study shows almost half of chronic urticaria patients are not receiving any treatment despite significant disease burden

20/06/2017 - 07:10

Urgent need to improve management of chronic urticaria (CU) - a disease that causes itchy, persistent hives and swelling which last more than 6 weeks or recur over months or years - highlighted by study of over 3,700 [...]

argenx receives second preclinical milestone payment in collaboration with LEO Pharma

20/06/2017 - 07:00

June 20, 2017 Breda, the Netherlands / Ghent, Belgium - argenx (Euronext & Nasdaq: ARGX), a clinical-stage biotechnology company developing a deep pipeline of differentiated antibody-based therapies for the [...]

NEOVACS ANNONCE LA FIN DU RECRUTEMENT DES PATIENTS POUR SON ETUDE CLINIQUE DE PHASE IIB DANS LE TRAITEMENT DU LUPUS

20/06/2017 - 07:00

NEOVACS ANNONCE LA FIN DU RECRUTEMENT DES PATIENTS POUR SON ETUDE CLINIQUE DE PHASE IIB DANS LE TRAITEMENT DU LUPUS Perspective de publication des résultats cliniques au cours du deuxième trimestre 2018 Paris et Boston [...]

NEOVACS ANNOUNCES THE COMPLETION OF PATIENT ENROLLMENT IN PHASE IIB CLINICAL STUDY OF IFNalpha KINOID IN LUPUS

20/06/2017 - 07:00

NEOVACS ANNOUNCES THE COMPLETION OF PATIENT ENROLLMENT IN PHASE IIB CLINICAL STUDY OF IFNalpha KINOID IN LUPUS Company Expects the Availability of Results from the Study in Q2 2018 Paris and Boston, June 20, 2017 - 7:00 [...]

Takeda and TiGenix announce that Swissmedic has accepted for review the file on Cx601 for the treatment of complex perianal fistulas in Crohn's disease patients

20/06/2017 - 07:00

PRESS RELEASE Takeda and TiGenix announce that Swissmedic has accepted for review the file on Cx601 for the treatment of complex perianal fistulas in Crohn's disease patients Pfäffikon, SZ, June 20, 2017, and Leuven, [...]

Takeda et TiGenix annoncent que Swissmedic a accepté la demande d'évaluation relative au Cx106 pour le traitement des fistules périanales complexes chez les patients atteints de la maladie de Crohn.

20/06/2017 - 07:00

COMMUNIQUÉ DE PRESSE Takeda et TiGenix annoncent que Swissmedic a accepté la demande d'évaluation relative au Cx106 pour le traitement des fistules périanales complexes chez les patients atteints de la maladie de Crohn [...]

Immunicum Announces Publication in Journal for ImmunoTherapy of Cancer of Results Overview from Ilixadencel's First Clinical Study in Metastatic Renal Cell Carcinoma

20/06/2017 - 02:01

Press Release 20 June 2017 Immunicum Announces Publication in Journal for ImmunoTherapy of Cancer of Results Overview from Ilixadencel's First Clinical Study in Metastatic Renal Cell Carcinoma Immunicum AB (publ; First [...]

Sanofi : Disclosure of trading in own shares

19/06/2017 - 19:15

Reporting EN This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients. The issuer of this announcement warrants that they are solely responsible for the [...]

Sanofi : Déclaration des transactions sur actions propres

19/06/2017 - 19:15

Reporting FR This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients. The issuer of this announcement warrants that they are solely responsible for the [...]

Ossur Hf : Transactions in relation to share buyback program

19/06/2017 - 18:00

Announcement from Össur hf. No. 45/2017 Reykjavík, 19 June 2017 On 1 December 2016, Össur hf. initiated a new share buy-back program, see Company announcement no. 96/2016. The purpose of the share buyback program is to [...]

Helén Tuvesson new CEO of Active Biotech AB from July 1, 2017

19/06/2017 - 15:30

PRESS RELEASE Lund - Active Biotech AB (Nasdaq Stockholm: ACTI) today announces that the Board has appointed the company's current CSO Helén Tuvesson as new CEO of Active Biotech AB. Helén Tuvesson will take up the [...]

Novo Nordisk A/S - Share repurchase programme

19/06/2017 - 14:48

Bagsværd, Denmark, 19 June 2017 - On 2 February 2017, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No. 596/2014 of the European Parliament and Council of 16 April 2014 ( [...]

Extrodinary General Shareholders' Meeting

19/06/2017 - 14:30

NEWS RELEASE IRVINE, CA, and HERSTAL, BELGIUM - 14:30 CEST, June 19 2017 - MDxHealth SA (Euronext: MDXH.BR) held today its Extraordinary General Shareholders' Meeting in Brussels. The shareholders approved all agenda [...]

Assemblée Générale Extraordinaire des Actionnaires

19/06/2017 - 14:30

COMMUNIQUE DE PRESSE IRVINE, CA, et HERSTAL, BELGIQUE, le 19 juin , 14:30 CEST - MDxHealth SA (Euronext: MDXH.BR) a tenu aujourd'hui son Assemblée Générale Extraordinaire des Actionnaires à Bruxelles. Les actionnaires [...]

Eckert & Ziegler BEBIG: Meeting Minutes Annual General Meeting

19/06/2017 - 13:57

Seneffe, June 19, 2017. The Minutes and all relevant documents regarding the Annual General Meeting 2017 can be downloaded on the website: http://www.bebig.com/home/investors/shareholder_information/ About Eckert & [...]

Eckert & Ziegler BEBIG: Procès verbal de l'assemblée générale des actionnaires

19/06/2017 - 13:57

Seneffe, le 19 juin 2017. Le procès verbal ainsi que tous les documents relatifs à l'Assemblé Générale 2017 peuvent être téléchargés sur le site internet: http://www.bebig.com/home/investors/shareholder_information/ A [...]